PDI - Resultado de Búsqueda

nigel peter murray

Profesor

Universidad Finis Terrae

Santiago, Chile

La detección y caracterización of CTCs y metástasis en cáncer de próstata y del colon, el efecto de la enfermedad mínimo residual en el pronostico y la influencia del sistema inmunología en la respuesta de pacientes con cáncer no-metastásica.

Hematología, CONACEM. Chile, 1995
Cell and Immunobiology BSc (Hons), university of wales. Reino Unido, 1982
MB BCH, university of wales. Reino Unido, 1987
Medicina Interna, Royal College of Physicians UK. Chile, 1992
medico cirujano, UNIVERSIDAD DE CHILE. Chile, 1994

REgistrar Full Time

UNIVERSITY OF LIVERPOOL

Medicine

Liverpool, Reino Unido

1990 - 1993
Lecturer Full Time

University of Manchester

medicina

Manchester, Reino Unido

1993 - 1994
Lecturer Part Time

Universidad Mayor

Medicina

Santiago, Chile

2008 - 2015
Profesor Full Time

Universidad Finis Terrae

Medicina

Santiago, Chile

2015 - A la fecha

Director -Médico Part Time

Instituto Bio-Oncologia

Santiago, Chile

1996 - 2015

Ganador el Premio Perez-Castro por el mejor articulo de investigación publicado en los Archivos Españoles de Urología
2011.2012, 2017 y 2019, finalista 2014 y 2015

Ganador el Galardón Umberto Veronesi (Instituto Europeo de Oncología) 2016 Buenas Aires y 2017 Montevideo por el mejor trabajo científico

Ganador Premio SLAURO 2016 Santiago por el mejor trabajo cientifico

Ganador Premio SLAGO 2017 Santiago por el mejor trabajo científico en cáncer del colon

Ganador Premio Mejor presentación científico Congreso Internacional Congreso de Molecular Oncolgía, Grecia 2011

Nigel P Murray

UNIVERSIDAD FINIS TERRAE

Chile, 2019

1ª premio Prez Castro mejor articulo de investigación publicado en los Archivos Españoles de Urológica 2019. 2017, 2012 y 2011 POR LOS TRABAJOS EN CTCS, Y LA ENFERMEDAD MINIMA RESIDUAL
Nigel P Murray

UNIVERSIDAD FINIS TERRAE

Chile, 2016

PREMIO SLAURO POR EL MEJOR TRABAJO EN CTCS EN CÁNCER PROSTÁTICO
Nigel P Murray

UNIVERSIDAD FINIS TERRAE

Chile, 2016

GANADOR PREMIO POR EL MEJOR TRABAJO CIENTÍFICO EN CÁNCER DEL PRÓSTATA 2016 GALARDÓN UMBERTO VERONESI INSTITUTO EUROPEO DE ONCOLOGÍA, BUENOS AIRES


Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study Murray, Nigel P.; Reyes, Eduardo; Salazar, Anibal; Minzer, Simona; Orrego, Shenda Article ISI UROLOGY JOURNAL (2020)
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy Reyes, Eduardo Article ISI ECANCERMEDICALSCIENCE (2020)
Biomarkers detecting minimal residual disease in solid tumors: what do they mean in the clinical management of patients? Article ISI SCOPUS BIOMARKERS IN MEDICINE (2019)
Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer [CÉlulas prostÁticas circulantes y micro-metÁstasis en mÉdula Ósea determinantes en el riesgo y en el tiempo de progresiÓn bioquÍmica en cÁncer prostÁtico localizado] Article SCOPUS Archivos Espanoles de Urologia (2019)
Common B-cell acute lymphoblastic leukaemia in a 70-year-old woman presenting 2 years after carboplatin-taxane radiotherapy for endometrial cancer Lopez M.A. Article SCOPUS ecancermedicalscience (2019)
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse Villalon R. Article SCOPUS ecancermedicalscience (2019)
Minimal residual disease and not the treatment predicts biochemical recurrence in patients with low-risk prostate cancer [La enfermedad mínima residual y no el tratamiento predice la recidiva bioquímica en sujetos con cáncer prostático de bajo riesgo] Lopez M.A. Article SCOPUS Archivos Espanoles de Urologia (2019)
Predictive value of neutrophil to lymphocyte ratio in the diagnosis of significant prostate cancer at initial biopsy: A comparison with free percent prostate specific antigen, prostate specific antigen density and primary circulating prostate cells Article SCOPUS Asian Pacific Journal of Cancer Prevention (2019)
Primary circulating prostate cells, age, and prostate volume predict prostate cancer in subjects with indication of a second prostate biopsy [Las células prostáticas circulantes primarias, edad y volumen prostático predicen el cáncer prostático en sujetos con indicación de una segunda biopsia prostática] Article SCOPUS Archivos Espanoles de Urologia (2019)
Short-term dose-escalated romiplostim for preparing an adult patient with persistent newly diagnosed primary immune thrombocytopenia for splenectomy Article SCOPUS Hematology, Transfusion and Cell Therapy (2019)
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy Lopez M.A. Article SCOPUS ecancermedicalscience (2019)
10 year biochemical failure free survival of men with CD82 positive primary circulating prostate cells treated by radical prostatectomy Article SCOPUS Asian Pacific Journal of Cancer Prevention (2018)
Combining the Prostate Cancer Risk Index (PRIX) with the presence of secondary circulating prostate cells to predict the risk of biochemical failure after radical prostatectomy for prostate cancer Jacob, O Article SCOPUS Asian Pacific Journal of Cancer Prevention (2018)
Minimum residual disease in patients post radical prostatectomy for prostate cancer: Theoretical considerations, clinical implications and treatment outcome Article SCOPUS Asian Pacific Journal of Cancer Prevention (2018)
Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy Article ISI ARCHIVOS ESPANOLES DE UROLOGIA (2017)
Comparison between use of PSA kinetics and bone marrow micrometastasis to define local or systemic relapse in men with biochemical failure after radical prostatectomy for prostate cancer Reyes, E; Fuentealba, C; Orellana, N.; Jacob, O Article SCOPUS Asian Pacific Journal of Cancer Prevention (2016)
Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer Article ISI SCOPUS UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells Article ISI SCOPUS BJU INTERNATIONAL (2016)
Comparison of the formula of PSA, age, prostate volume and race versus PSA density and the detection of primary malignant circulating prostate cells in predicting a positive initial prostate biopsy in chilean men with suspicion of prostate cancer Reyes, E; Fuentealba, C; Orellana, N.; Morales F.; Jacob, O Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
Comparison of the Walz nomogram and presence of secondary circulating prostate cells for predicting early biochemical failure after radical prostatectomy for prostate cancer in chilean men Reyes, E; Orellana, N.; Fuentealba, C; Jacob, O Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: The BEST (breast early screening test) study Miranda, R.; Ruiz A.; Droguett E. Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
Expression of P504S and matrix metalloproteinase-2 in circulating prostate cells disseminated as a result of transrectal ultrasound guided biopsy as determined by immunocytochemistry: Clinical implications Reyes, E; Orellana, N.; Fuentealba, C; Dueñas R; Jacob, O Article SCOPUS Archivos Espanoles de Urologia (2015)
Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer Reyes, E; Fuentealba, C; Orellana, N.; Jacob, O; Badilla S. Article SCOPUS Urologic Oncology: Seminars and Original Investigations (2015)
Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer. Murray, Nigel P; Reyes, Eduardo; Fuentealba, Cynthia; Orellana, Nelson; Jacob, Omar; Badilla, Sebastian Article Urologic oncology (2015)
Possible role of HER-2 in the progression of prostate cancer from primary tumor to androgen independence Reyes, E; Fuentealba, C; Jacob, O; Orellana, N. Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
Prostate cancer screening in the fit chilean elderly: A head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy Reyes, E; Orellana, N.; Fuentealba, C; Jacob, O Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
Secondary circulating tumor cells (CTCs) but not primary CTCs are associated with the clinico-pathological parameters in chilean patients with colo-rectal cancer Albarran V.; Perez G.; Villalon R.; Ruiz A. Article SCOPUS Asian Pacific Journal of Cancer Prevention (2015)
A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men. Murray, Nigel P; Reyes, Eduardo; Orellana, Nelson; Fuentealba, Cynthia; Dueñas, Ricardo Article BioMed research international (2014)
Elimination of primary circulating prostate cells after radical prostatectomy for prostate cancer decreases the risk of future biochemical failure Reyes, E; Orellana, N.; Fuentealba, C; Dueñas R Article SCOPUS Archivos Espanoles de Urologia (2014)
Primary circulating prostate cells are not detected in men with low grade small volume prostate cancer Reyes, E; Fuentealba, C; Orellana, N.; Jacob, O Article SCOPUS Journal of Oncology (2014)
Screening for prostate cancer: New markers and future aspects Article SCOPUS Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis (2014)
A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy Reyes, E; Tapia, P; Orellana, N.; Fuentealba, C Article SCOPUS Archivos Espanoles de Urologia (2013)
Circulating prostate cells found in men with benign prostate disease are P504S negative: Clinical implications Reyes, E; Orellana, N.; Fuentealba, C; Porcell J. Article SCOPUS Journal of Oncology (2013)
Cost-benefit of incorporating the detection of circulating prostate cells in a screening programme for prostate cancer Reyes, E; Orellana, N.; Tapia, P Article SCOPUS Archivos Espanoles de Urologia (2013)
Effect of androgen blockade on HER-2 and matrix metalloproteinase-2 expression on bone marrow micrometastasis and stromal cells in men with prostate cancer. Murray, N P; Reyes, E; Badinez, L; Orellana, N; Fuentealba, C; Olivares, R; Porcell, J; Dueñas, R Article TheScientificWorldJournal (2013)
Secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of disease. Murray, Nigel P; Reyes, Eduardo; Orellana, Nelson; Fuentealba, Cynthia; Bádinez, Leonardo; Olivares, Ruben; Porcell, José; Dueñas, Ricardo Article TheScientificWorldJournal (2013)
Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatecto Murray, N P; Reyes, E; Tapia, P; Badinez, L; Orellana, N; Fuentealba, C; Olivares, R; Porcell, J; Dueñas, R Article International journal of molecular medicine (2012)
Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy Reyes, E; Tapia, P; Badinez L.; Orellana, N.; Fuentealba, C; Olivares R.; Porcell J.; Dueñas R Article ISI SCOPUS International Journal of Molecular Medicine (2012)
Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: Comparison to prostatic biopsy Rendimiento diagnóstico de la detección de células prostáticas malignas en la circulación sanguínea para la detección precoz de cáncer prostático: UNA comparación con la biopsia prostática Reyes, E; Tapia, P; Orellana, N.; Dueñas R; Fuentealba, C; Badinez L. Article SCOPUS Archivos Espanoles de Urologia (2011)
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol Badinez L.V.; Duenas R.R.; Orellana, N.; Tapia, P Article SCOPUS Indian Journal of Urology (2011)
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol. Murray, Nigel P; Badinez, Leonardo V; Dueñas, Ricardo R; Orellana, Nelson; Tapia, Pablo Article Indian journal of urology : IJU : journal of the Urological Society of India (2011)
Detection and characteristics of primary circulating prostate cells; association with micrometastasis and implications for surgical treatment of men with prostate cncer [Deteccin y caractersticas de clulas prostticas circulantes primarias, asociacin con la presencia de micrometstasis y las implicaciones para el tratamiento quirrgico en hombres con cncer prosttico] Reyes, E; BadÂ’nez L.; Orellana, N.; DueÂ–as R.; Fuentealba, C Article SCOPUS ARCHIVOS ESPANOLES DE UROLOGIA (2010)
P504S expressing circulating prostate cells as a marker for prostate cancer Calaf, G. M.; Badinez L.; DueÃ±a R.; Badinez O.; Orellana, N.; Reyes, E; Fuentealba, C Article ISI SCOPUS ONCOLOGY REPORTS (2010)


Manejo de una paciente embarazada con déficit congénito de Factor VII leve Nigel P Murray; Javier Ilabaca; Miguel Biron; Cristian Pinats; Simona Minzer CaseReport SCIELO SCOPUS Revista chilena de obstetricia y ginecologï¿½a (2019)
ANTICUERPO ANTI-P1 Y EMBARAZO Nigel P Murray CaseReport SCIELO Revista chilena de obstetricia y ginecologï¿½a (2003)


Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer Note ISI SCOPUS JOURNAL OF UROLOGY (2019)


Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management Murray, NP Review ISI SCIELO BIOLOGICAL RESEARCH (2018)
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy Murray, NP; Reyes, E; Minzer, S Review WOS-ESCI SCOPUS ECANCERMEDICALSCIENCE (2018)

Pablo Tapia

Jefe Técnico Unidad de Paciente Crítico (UPC)

Unidad Paciente Critico (UPC)

Hospital Clinico Metropolitano La Florida

Santiago, Chile

Gloria Calaf

Jefe Laboratorio Biología del Cáncer

Universidad de Tarapacá

Arica, Chile

Cynthia Fuentealba

Médico Urólogo

Urología

Hospital DIPRECA

Santiago, Chile

nigel murray

Profesor

Medicina

Universidad Finis Terrae

Santiago, Chile

nigel peter murray

Líneas de Investigación

Educación

Hematología, CONACEM. Chile, 1995

Cell and Immunobiology BSc (Hons), university of wales. Reino Unido, 1982

MB BCH, university of wales. Reino Unido, 1987

Medicina Interna, Royal College of Physicians UK. Chile, 1992

medico cirujano, UNIVERSIDAD DE CHILE. Chile, 1994

Experiencia Académica

REgistrar Full Time

Lecturer Full Time

Lecturer Part Time

Profesor Full Time

Experiencia Profesional

Director -Médico Part Time

Formación de Capital Humano

Premios y Distinciones

Nigel P Murray

Nigel P Murray

Nigel P Murray

Article (43)

CaseReport (2)

Note (1)

Review (2)